Study reveals biological mechanism behind therapy resistance in advanced prostate cancer

A collaborative study led by the University of Chicago and Fred Hutchinson Cancer Center has uncovered a new biological mechanism that influences cell identity and treatment resistance in advanced prostate cancer. This discovery could provide new insights for developing more effective therapies against resistant forms of the disease.

Originally published by gnews